Search research articles
Contact Us
Filters
Showing results (21-30 of 104) with videos related to
Page
of 11
Sort By:
The American Journal of Case Reports
|
April 23, 2014
The potent synergistic effects of the combination of liraglutide and canagliflozin on glycemic control and weight loss
David S H Bell
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
August 15, 2022
Diabetic Mononeuropathies and Diabetic Amyotrophy
David S H Bell
Journal of Diabetes Research
|
August 15, 2022
Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy
David S H Bell
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 14, 2021
Are the Protean Effects of Pentoxifylline in the Therapy of Diabetes and Its Complications Still Relevant?
David S H Bell
Cardiology Clinics
|
December 8, 2007
Heart failure in the diabetic patient
David S H Bell
Clinical Therapeutics
|
January 11, 2005
Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy
David S H Bell
Postgraduate Medicine
|
December 15, 2015
Aspirin in the prevention of cardiovascular events in patients with diabetes
David S H Bell
Southern Medical Journal
|
June 10, 2010
Resolution of statin-induced myalgias by correcting vitamin D deficiency
David S H Bell
Southern Medical Journal
|
May 25, 2011
Protean manifestations of vitamin D deficiency, part 1: the epidemic of deficiency
David S H Bell
Diabetes, Obesity & Metabolism
|
February 7, 2023
Detecting and treating the protean manifestations of diabetic autonomic neuropathy
David S H Bell
Page
of 11
Search research articles
Search
Showing results (21-30 of 104) with videos related to
Sort By:
Page
of 11
The American Journal of Case Reports
|
April 23, 2014
The potent synergistic effects of the combination of liraglutide and canagliflozin on glycemic control and weight loss
David S H Bell
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
August 15, 2022
Diabetic Mononeuropathies and Diabetic Amyotrophy
David S H Bell
Journal of Diabetes Research
|
August 15, 2022
Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy
David S H Bell
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
October 14, 2021
Are the Protean Effects of Pentoxifylline in the Therapy of Diabetes and Its Complications Still Relevant?
David S H Bell
Cardiology Clinics
|
December 8, 2007
Heart failure in the diabetic patient
David S H Bell
Clinical Therapeutics
|
January 11, 2005
Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy
David S H Bell
Postgraduate Medicine
|
December 15, 2015
Aspirin in the prevention of cardiovascular events in patients with diabetes
David S H Bell
Southern Medical Journal
|
June 10, 2010
Resolution of statin-induced myalgias by correcting vitamin D deficiency
David S H Bell
Southern Medical Journal
|
May 25, 2011
Protean manifestations of vitamin D deficiency, part 1: the epidemic of deficiency
David S H Bell
Diabetes, Obesity & Metabolism
|
February 7, 2023
Detecting and treating the protean manifestations of diabetic autonomic neuropathy
David S H Bell
Page
of 11